Table 4. Isolates from blood cultures (n = 1212).
| Isolate from blood culture | Number of positive cultures |
| S. enterica Typhi | 22a (1.8%) |
| S. pneumoniae | 13b (1.1%) |
| E. coli | 8c (0.7%) |
| H. influenzae | 7 (0.6%) |
| B. pseudomallei | 6e (0.5%) |
| S. aureus | 6d (0.5%) |
| K. pneumoniae | 4f (0.3%) |
| Acinetobacter baumannii | 3 (0.2%) |
| N. meningitidis | 2 (0.2%) |
| S. pyogenes | 2 (0.2%) |
| Yeast | 1 (<0.1%) |
| Pantoea spp. | 1 (<0.1%) |
| P. aeruginosa | 1 (<0.1%) |
| Total true isolates | 76 (6.3%) |
| Isolates of uncertain significance | |
| Unidentified Gram-negative bacilli | 5 (0.4%) |
| Pseudomonas spp. | 5 (0.4%) |
| Acinetobacter calcoaceticus | 4 (0.3%) |
| Ochrobactum anthropi | 3 (0.2%) |
| Burkholderia cepacia | 2 (0.2%) |
| Moraxella spp. | 2 (0.2%) |
| Alcaligenes faecalis | 1 (0.1%) |
| Gemella morbillorum | 1 (0.1%) |
| Sphingobacterium spiritivorum | 1 (0.1%) |
| Stenotrophomonas maltophilia | 1 (0.1%) |
| Streptococcus sanguinis | 1 (0.1%) |
| Total isolates of uncertain significance | 26 (2.1%) |
| Contaminants | 60g (5.0%) |
a
19/21 (90.5%) had intermediate susceptibility to ciprofloxacin; 18/21 (85.7%) were multi-drug resistant (resistant to chloramphenicol, ampicillin and co-trimoxozole).
b
8 strains were available for testing, all were susceptible to ceftriaxone.
c
4 strains were available for testing, one was ESBL producing.
d
6 strains available for testing, one was MRSA.
e
Constitutively resistant to ceftriaxone.
f
2 strains available for testing, one was ESBL producing.
g
33 coagulase-negative staphylococci, 27 Gram-positive bacilli.